{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T17:57:17Z","timestamp":1700071037545},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.transproceed.2009.06.064","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T04:52:06Z","timestamp":1251348726000},"page":"2334-2336","source":"Crossref","is-referenced-by-count":7,"title":["Switching to Sirolimus in Renal Transplant Recipients With Hepatitis C Virus: A Safe Option"],"prefix":"10.1016","volume":"41","author":[{"given":"R.","family":"Gallego","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Henriquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Hortal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Sabl\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Palop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2009.06.064_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"issue":"suppl 5","key":"10.1016\/j.transproceed.2009.06.064_bib2","first-page":"62","article-title":"Trasplante renal en pacientes virus de la hepatitis C positivos","volume":"22","author":"Campistol","year":"2002","journal-title":"Nefrologia"},{"key":"10.1016\/j.transproceed.2009.06.064_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1034\/j.1600-6143.2001.10213.x","article-title":"Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival","volume":"1","author":"Batty","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2009.06.064_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1034\/j.1600-6143.2001.10212.x","article-title":"Hepatitis C virus infection and de novo glomerular lesions in renal allografts","volume":"1","author":"Cruzado","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2009.06.064_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1600-6143.2003.00057.x","article-title":"Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance","volume":"3","author":"Cruzado","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2009.06.064_bib6","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/j.1600-6143.2005.00864.x","article-title":"Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies","volume":"5","author":"Fabrizi","year":"2005","journal-title":"Am J Transplant"},{"issue":"suppl 4","key":"10.1016\/j.transproceed.2009.06.064_bib7","first-page":"4","article-title":"European best practice guidelines for renal transplantation","volume":"17","year":"2002","journal-title":"Neprhol Dial Transplant"},{"key":"10.1016\/j.transproceed.2009.06.064_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00007890-200107150-00013","article-title":"Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss?","volume":"72","author":"Marcen","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.06.064_bib9","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0041-1345(03)00612-2","article-title":"Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions","volume":"35","author":"Ruiz","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2009.06.064_bib10","first-page":"386","article-title":"Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantation for HCV cirrhosis","volume":"11","author":"Samonakis","year":"2005","journal-title":"Hepatol"},{"key":"10.1016\/j.transproceed.2009.06.064_bib11","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0016-5085(99)70406-3","article-title":"Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis","volume":"117","author":"Zhu","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2009.06.064_bib12","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/jpet.104.079616","article-title":"Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms","volume":"313","author":"Biecker","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.transproceed.2009.06.064_bib13","unstructured":"Forman LM, Kam I, Everson GT: Maintenance of excellent patient survival after liver transplantation for chronic hepatitis c in a single center during three eras of inmunosuppression characterized by wide variation in use of OKT3. Presented at the American Transplant Congress, May 14\u201319, Boston, Mass."}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134509007969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134509007969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T10:56:23Z","timestamp":1545044183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134509007969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0041134509007969"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2009.06.064","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}